Cancer Immunotherapy Market By Product (Cancer Vaccines, Oncolytic Viral Therapies, Monoclonal Antibodies and Immunomodulators) and Cancer Type (Pancreatic Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer and Head & Neck Cancer) - Global Industry Analysis And Forecast To 2025

Industry Outlook

Cancer Immunotherapy is a type of treatment that makes use of some parts of person’s immune system to fight the disease. Cancer Immunotherapy works in the following ways; one is stimulating the immune system to work smarter & harder to fight the cancer cells and the other way is providing man-made immune system components to immune system. Immunotherapy is also sometimes called as biotherapy or biologic therapy. Research for newer techniques to immune treatment is done for improving the impact on treatment of cancer in future. Cancer Immunotherapy use is growing owing to; ongoing research in the field of chemo immunotherapy, increasing number of cases related to cancer, technical development in the therapies for treatment, increase in the R&D for treatment of cancer, etc. Therefore, the Cancer Immunotherapy Market is anticipated to expand and has tremendous scope during the forecast period. The global Cancer Immunotherapy Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Cancer Immunotherapy Market is based on segment, by Product the market is segmented into Cancer Vaccines, Oncolytic Viral Therapies, Monoclonal Antibodies and Immunomodulators, and by Cancer Type the market is segmented into Pancreatic Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer and Head & Neck Cancer.


Cancer Immunotherapy Market, By Product

Cancer Vaccines
Oncolytic Viral Therapies
Monoclonal Antibodies
Immunomodulators

Cancer Immunotherapy Market, By Cancer Type

Pancreatic Cancer
Lung Cancer
Melanoma
Ovarian Cancer
Prostate Cancer
Breast Cancer
Colorectal Cancer
Head & Neck Cancer


Regional Insights

On a global front, the Cancer Immunotherapy Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Cancer Immunotherapy Market owing to high number of aged population, modern treatments available, increasing cases of disorders, etc.

Cancer Immunotherapy Market, By Region


North America


U.S.
Canada
Mexico


Europe

Germany
UK
France
Russia
Italy
Rest of Europe


Asia-Pacific

China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific


South America

Brazil
Argentina
Columbia
Rest of South America


Middle East and Africa

Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA




Competitive Analysis

The leading players in the market are Pfizer Inc., Novartis AG, Amgen Inc., Merck and Co. Inc., AstraZeneca, Immunomedics Inc., F. Hoffmann La Roche Ltd., Eli Lilly and Company, Bayer AG, Bristol-Myers Squibb Company and Advaxis Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.


Pfizer Inc.
Novartis AG
Amgen Inc.
Merck and Co. Inc.
AstraZeneca
Immunomedics Inc.
F. Hoffmann La Roche Ltd.
Eli Lilly and Company
Bayer AG
Bristol-Myers Squibb Company
Advaxis Inc.


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?